A detailed history of Css LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Css LLC holds 2,250 shares of UTHR stock, worth $740,812. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,250
Previous 2,550 11.76%
Holding current value
$740,812
Previous $560,000 7.86%
% of portfolio
0.06%
Previous 0.07%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $63,228 - $74,853
-300 Reduced 11.76%
2,250 $516,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $21,488 - $25,694
100 Added 4.08%
2,550 $560,000
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $74,137 - $86,884
-350 Reduced 12.5%
2,450 $553,000
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $61,557 - $69,897
300 Added 12.0%
2,800 $618,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $149,093 - $193,319
700 Added 38.89%
2,500 $559,000
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $20,595 - $28,043
-100 Reduced 5.26%
1,800 $500,000
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $81,320 - $97,668
-400 Reduced 17.39%
1,900 $398,000
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $52,443 - $72,342
300 Added 15.0%
2,300 $542,000
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $332,320 - $427,920
2,000 New
2,000 $359,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.